Clinical Trial

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, pilot study to assess the impact of a 12-month multi-focal lifestyle intervention on myeloma-relevant biomarkers in patients with MGUS or SM. The multimodal lifestyle intervention has six foci that patients will participate in over the course of one-year.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2028-05-01 -> 2028-07-01 2026-06-16
minor Completion pushed: 2028-05-01 -> 2028-07-01 2026-06-16
Trial Details
NCT Number NCT06987708
Lead Sponsor Hackensack Meridian Health
Collaborators: Center for Cancer Lifestyle Management
Conditions Monoclonal Gammopathy of Uncertain Significance, Smoldering Myeloma
Enrollment 67 participants
Start Date 2026-07-01
Primary Completion 2028-07-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-15